|

A Platform Study for solId orgaN CancERs

RECRUITINGSponsored by University of Liverpool
Actively Recruiting
SponsorUniversity of Liverpool
Started2022-01-01
Est. completion2030-01-01
Eligibility
Age16 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05650125

Summary

Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.

Eligibility

Age: 16 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Biopsy or surgical resection as standard of care

Exclusion Criteria:

* Refusal or inability to consent, paediatric patients

Conditions2

CancerSurgery

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.